Cross-reactivity of amphetamine analogues with Roche Abuscreen radioimmunoassay reagents.
Cross-reactivity of amphetamine analogues with the Abuscreen amphetamine radioimmunoassay reagents was determined for both the standard and high specificity antibody systems. Compounds tested included 2-methoxyamphetamine, 4-hydroxymethamphetamine, 2,5-dimethoxyamphetamine (DMA), 4-bromo-2,5-dimethoxyamphetamine (DOB), 4-bromo-2,5-dimethoxy-beta-phenethylamine (BDMPEA), 3,4,5-trimethoxyamphetamine (TMA), 3,4-methylenedioxyamphetamine (MDA), N,N-dimethyl-3,4-methylenedioxyamphetamine and N-hydroxy-3,4-methylenedioxyamphetamine (N-OH MDA), 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyethylamphetamine (MDEA), 2,5-dimethoxy-4-ethylamphetamine, 2,5-dimethoxy-4-methylamphetamine (DOM), and 3,4,5-trimethoxyphenethylamine (mescaline). Blank negative reference material was spiked with 1,000 to 100,000 ng/mL of the amphetamine analogue and used as sample in the assays. MDA was the only analogue that showed cross reactivity equal to or greater than that of amphetamine. None of the other analogue compounds demonstrated a positive result at even the highest concentration; however several showed depressed counts at various concentration levels.
Cody
J T
JT
Air Force Drug Testing Laboratory, Brooks AFB, TX 78235-5000.
D015104:3,4-Methylenedioxyamphetamine / Q000032:analysis; D000662:Amphetamines / Q000032:analysis*; D003429:Cross Reactions; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007202:Indicators and Reagents; D007457:Iodine Radioisotopes; D011863:Radioimmunoassay; D015813:Substance Abuse Detection / Q000295:instrumentation*; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000652:urine
D000662:Amphetamines; D007202:Indicators and Reagents; D007457:Iodine Radioisotopes; D015104:3,4-Methylenedioxyamphetamine